The influence of normal microbial flora on the development of chronic mucosal inflammation

Research in Immunology

Volumn 148, Issue 8-9, 1997, Pages 567-576

  Sartor, R B ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIGEN PRESENTATION; BACTERIAL COLONIZATION; CROHN DISEASE; ENTERITIS; GENETIC SUSCEPTIBILITY; HOST SUSCEPTIBILITY; IMMUNOPATHOGENESIS; INTESTINE FLORA; INTESTINE MUCOSA; INTESTINE MUCOSA PERMEABILITY; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; ULCERATIVE COLITIS;

EID: 0031253619     PISSN: 09232494     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-2494(98)80151-X     Document Type: Article

References (72)

1. Ambrose, N.S., Johnson, M., Burdon, D.W. & Keighley, M.R.B. (1984), Incidence of pathogenic bacteria from mesenteric lymph nodes and ileal serosa during Crohn's disease. Br. J. Surg., 71, 623-625.
2. high T cells into C.B-17 SCID mice in dependent on the presence of enteric bacteria. Gastroenterology, 110, A856.
3. Auer, I.O., Roder, A., Wensinck, F., van de Merwe, J.P. & Schmidt, H. (1983), Selected bacterial antibodies in Crohn's disease and ulcerative colitis. Scand. J. Gastroenterol., 189, 217-223.
4. Baldassano, R.N., Schreiber, S., Johnston, R.B., Jr., Fu, R.D., Muraki, T. & MacDermott, R.P. (1993), Crohn's disease monocytes are primed for accentuated release of toxic oxygen metabolites. Gastroenterology, 105, 60-66.
5. Bayliss, T.M., Tokayer, A.Z., Polito, II, J.M., Quaskey, S.A., Mellitis, E.D. & Harris, M.L. (1996), Crohn's disease: concordance for site and clinical type in affected family members - potential hereditary influences. Gastroenterology, 111, 573-580.
6. + Th 1-like response. J. Clin. Invest., 98, 1010-1020.
7. Braat, H., Dieleman, L.A., Sellon, R.K., Schultz, M. & Sartor, R.B. (1998), Effects of antibiotics on the initiation and perpetuation of colitis in the IL-10 KO mice. Gastroenterology, 114 (in press).
8. Brandwein, S.L., McCabe, R.P., Cong, Y., Waites, K.B., Ridwan, B.U., Dean, P.A., Ohkusa, T., Birkenmeier, E.H., Sundberg, J.P. & Elson, C.O. (1997), Spontaneously colitic C3H/HeJBir mice demonstrate selective antibody reactivity to antigens of the enteric bacterial flora. J. Immunol., 159, 44-52.
9. Bylund-Fellenius, A.-C., Landström, E., Axelsson, L.-G. & Midtvedt, T. (1994), Experimental colitis in rats induces low-grade endotoxemia without hepatobiliary abnormalities. Dig. Dis. Sci., 139, 1210-1215.
10. Chadwick, V.S. & Anderson, R.P. (1992), Microorganisms and their products in inflammatory bowel disease, in "Inflammatory Bowel Disease" (MacDermott R.P., Stenson W.) (pp. 241-258). Elsevier, New York.
11. Chester, J.F., Ross, J.S., Matt, R.A. & Weitzmann, S.A. (1985), Acute colitis produced by chemotactic peptides in rats and mice. Am. J. Pathol., 121, 284-290.
12. Cong, Y., Brandwein, S.L., Lazenby, A., McCabe, R.P., Birkenmeier, E.H., Sundberg, J.P. & Elson, C.O. (1996), Th1 CD4+ T cell reactivity in colitic C3H/HeJ Bir mice. Gastroenterology, 110, A887.
13. Davis, S.W., Holt, L.C. & Sartor, R.B. (1990), Luminal bacteria and bacterial polymers potentiate indomethacin-induced intestinal injury in the rat. Gastroenterology, 98, A444.
14. D'Haens, G., Goboes, K., Peeters, M., Baert, F., Penninckx, F. & Rutgeerts, P. (1998), Early lesions caused by infusion of intestinal contents in excluded ileum in Crohn's disease. Gastroenterology, 114, 262-267.
15. Dianda, L., Hanby, A.M., Wright, N.A., Sebesteny, A., Hayday, A.C. & Owen, M.J. (1997), T cell receptor-αβ-deficient mice fail to develop colitis in the absence of a microbial environment. Am. J. Pathol., 150, 91-97.
16. Dieleman, L.A., Tonkonogy, S.L., Sellon, R.K. & Sartor, R.B. (1998), Helicobacter hepaticus does not potentiate colitis in interleukin-10 deficient mice. Gastroenterology, 114 (in press).
17. Duchmann, R., Kaiser, I., Hermann, E., Mayet, W., Ewe, K. & Meyer zum Büschenfelde, K.-K. (1995), Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin. Exp. Immunol., 102, 448-455.
18. Duchmann, R., Schmitt, E., Knolle, P., Meyer zum Büschenfelde, K.-H. & Neurath, M. (1996), Tolerance towards resident intestinal flora in mice in abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12. Eur. J. Immunol., 26, 934-938.
19. Elson, C.O., Sartor, R.B., Tennyson, G.S. & Riddell, R.H. (1995), Experimental models of inflammatory bowel disease. Gastroenterology, 109, 1344-1367.
20. Gardiner, K.R., Halliday, M.I., Barclay, G.R., Milne, L., Brown, D., Stephens, S., Maxwell, R.J. & Rowlands, B.J. (1995), Significance of systemic endotoxaemia in inflammatory bowel disease. Gut, 36, 897-901.
21. Gilat, T., Suissa, A., Leichtman, G., Delpre, G., Pavlotzky, M., Grossman, A. & Fireman, Z. (1987), A comparative study of metronidazole and sulfasalazine in active, not severe, ulcerative colitis. J. Clin. Gastroenterol., 9, 415-517.
22. Graham, D.Y., Al-Assi, M.T. & Robinson, M. (1995), Prolonged remission in Crohn's disease following therapy for Mycobacterium paratuberculosis infection [Abstract]. Gastroenterology, 108, A826.
23. Greenberg, G.R., Fleming, C.R., Jeejeebhoy, K.N., Rosenberg, I.H., Sales, D. & Tremaine, W.J. (1988), Controlled trial of bowel rest and nutritional support in the management of Crohn's disease. Gut, 29, 1309-1315.
24. Greenbloom, S.L., Steinhart, A.H. & Greenberg, G.R. (1995), Ciprofloxacin and metronidazole: combination antibiotic therapy for ileocolonic Crohn's disease. Gastroenterology, 108, A827.
25. Harper, P.H., Truelove, S.C., Lee, E.C.G., Kettlewell, M.G.W. & Jewell, D.P. (1983), Split ileostomy and ileocolostomy for Crohn's disease of the colon and ulcerative colitis: a 20 year survey. Gut, 24, 106-113.
26. Harper, P.H., Lee, E.C.G., Kettlewell, M.G.W., Bennett, M.K. & Jewell, D.P. (1985), Role of the faecal stream in the maintenance of Crohn's colitis. Gut, 26, 279-284.
27. Hazenberg, M.P., de Visser, H., Bras, M.J.J., Princ, M.E. & van de Merwe, J.P. (1990), Serum antibodies to peptidoglycan-polysaccharide complexes from the anaerobic intestinal flora in patients with Crohn's disease. Digestion, 47, 172-180.
28. Hermiston, M.L. & Gordon, J.I. (1995), Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin. Science, 270, 1203-1207.
29. Hilsden, R., Meddings, J.B. & Sutherland, L.R. (1996), Intestinal permeability changes in response to acetyl-salicylic acid in relatives of patients with Crohn' disease. Gastroenterology, 110, 1395-1403.
30. Hollander, D. (1993), Permeability in Crohn's disease: altered barrier function in healthy relatives? Gastroenterology, 104, 1848-1851.
31. Hugot, J.P., Laurent-Puig, P., Gower-Rousseau, C. & Olson, J.M. (1996), Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature, 379, 821-823.
32. Krok, A., Jarnet, G. & Danielsson, D. (1981), Clinical effect of metronidazole and sulfasalazine on Crohn's disease in relation to changes in the fecal flora. Scand. J. Gastroenterol., 16, 569-575.
33. Kühn, R., Löhler, J., Rennick, D., Rajewski, K. & Müller, W. (1993), Interleukin-10-deficient mice develop chronic enterocolitis. Cell, 75, 263-274.
34. Lichtman, S.N., Sartor, R.B., Schwab, J.H. & Keku, J. (1990), Hepatic inflammation in rats with experimental small bowel bacterial overgrowth. Gastroenterology, 98, 414-423.
35. Lichtman, S.N., Okoruwa, E.E., Keku, J., Schwab, J.H. & Sartor, R.B. (1992), Degradation of endogenous bacterial cell wall polymers by the muralytic enzyme mutanolysin prevents hepatobiliary injury in genetically susceptible rats with experimental intestinal bacterial overgrowth. J. Clin. Invest., 90, 1313-1322.
36. Liu, Y., van Kruiningen, H.J., West, A.B., Cartum, R.W., Cortot, A. & Colombel, J.F. (1995), Immunocytochemical evidence of Listeria, Escherichia coli, and streptococcus antigens in Crohn's disease. Gastroenterology, 108, 1396-1404.
37. Madsen, K.L., Tavernini, M.M., Doyle, J.S.G. & Fedorak, R.N. (1997), Lactobacillus SP prevents development of enterocolitis in interleukin-10 gene deficient mice. Gastroenterology, 112, A1030.
38. Mashimo, H., Deng-Chyang, W., Podolsky, D.K. & Fishman, M.C. (1996), Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor. Science, 274, 262-265.
39. McCall, R.D., Haskill, J.S., Zimmermann, E.M., Lund, P.K., Thompson, R.C. & Sartor, R.B. (1994), Tissue interleukin-1 and interleukin-1 receptor antagonist expression in enterocolitis in resistant and susceptible rats. Gastroenterology, 106, 960-972.
40. hi T cells. Res. Immunol., 145(5), 357-362.
41. Mizoguchi, A., Mizoguchi, E., Chiba, C. & Bhan, A.K. (1996), Role of appendix in the development of inflammatory bowel disease in TCR-α mutant mice. J. Exp. Med., 184, 707-715.
42. Onderdonk, A.B., Hermos, J.A., Drink, J.I. & Battlett, J.G. (1978), Protective effect of metronidazole in experimental ulcerative colitis. Gastroenterology, 74, 521-526.
43. Onderdonk, A.B., Franklin, M.L. & Cisneros, R.L. (1981), Production of experimental ulcerative colitis in gnotobiotic guinea pigs with simplified microflora. Infect. Immun., 32, 225-231.
44. Powell, J.J., Ainley, C.C., Harvey, R.S., Mason, I.M., Kendall, M.D., Sankey, E.A., Dhillon, A.P. & Thompson, R.P. (1996), Characterization of inorganic microparticles in pigment cells of human gut associated lymphoid tissue. Gut, 38, 390-395.
45. 2 microglobulin transgenic rats. J. Clin. Invest., 98, 945-953.
46. Rath, H.C., Ikeda, J.S., Wilson, K.H. & Sartor, R.B. (1997a), Cecal bacterial loads influence colitis and gastritis in HLA B27 transgenic rats. Gastroenterology, 112, A1068.
47. Rath, H.C., Schultz, M., Grenther, W.B., Wilson, K.H., Tonkonogy, S.L., Taurog, J.D., Hammer, R.E. & Sartor, R.B. (1997b), Colitis, gastritis and antibacterial lymphocyte responses in HLA-B27 transgenic rats monoassociated with Bacteroides vulgatus or Escherichia coli. Gastroenterology, 112, A1068.
48. Rath, H.C., Schultz, M., Dieleman, L.A., Li, F., Kölbl, H., Falk, W., Schölmerich, J. & Sartor, R.B. (1998), Selective vs. broad spectrum antibiotics in the prevention and treatment of experimental colitis in two rodent models. Gastroenterology, 114 (in press).
49. Robert, A. & Asano, T. (1977), Resistance of germfree rats to indomethacin-induced intestinal lesions. Prostaglandins, 14, 333-341.
50. Rutgeerts, P., Goboes, K., Peeters, M. et al. (1991), Effect of fecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum. Lancet, 338, 771-774.
51. Sadlack, B., Merz, H., Schorle, H., Schimpl, A., Feller, A.C. & Horak, I. (1993), Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell, 75, 253-261.
52. Sartor, R.B., Bond, T.M. & Schwab, J.H. (1988), Systemic uptake and intestinal inflammatory effects of luminal bacterial cell wall polymers in rats with acute colonic injury. Infect. Immun., 56, 2101-2108.
53. Sartor, R.B., Bender, D.E., Allen, J.B. et al. (1993), Chronic experimental enterocolitis and extraintestinal inflammation are T lymphocyte dependent. Gastroenterology, 104, A775.
54. Sartor, R.B., Bender, D.E., Grenther, T. & Holt, L.C. (1994), Absolute requirement for ubiquitous luminal bacteria in the pathogenesis of chronic intestinal inflammation. Gastroenterology, 106, A767.
55. Sartor, R.B. (1995a), Current concepts of the etiology and pathogenesis of Crohn's disease and ulcerative colitis. Gastroenterol. Clin. North Am., 24, 475-508.
56. Sartor, R.B. (1995b), Microbial factors in the pathogenesis of Crohn's disease, ulcerative colitis and experimental intestinal inflammation, in "Inflammatory Bowel Disease", 4th ed. (Kirsner J.B., Shorter R.G.) (pp. 96-124). Williams & Wilkins, Baltimore.
57. Sartor, R.B. (1995c), Insights into the pathogenesis of inflammatory bowel disease provided by new rodent models of spontaneous colitis. Inflam. Bowel Dis., 1, 64-75.
58. Sartor, R.B., De La Cadena, R.A., Green, K.D. et al. (1996), Selective kallikrein-kinin system activation in inbred rats differentially susceptible to granulomatous enterocolitis. Gastroenterology, 110, 1467-1481.
59. Sartor, R.B. (1997), Enteric microflora in IBD: pathogens or commensals? Inflam. Bowel Dis., 3, 230-235.
60. Satsangi, J., Parkes, M., Louis, E. et al. (1996), Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7, and 12. Nature Genet., 14, 199-202.
61. Saverymuttu, S., Hodgson, H.J.F. & Chadwick, V.A. (1985), Controlled trial comparing prednisolone with an elemental diet plus non-absorbable antibiotics in active Crohn's disease. Gut, 26, 994-998.
62. Schultz, M. & Sartor, R.B. (1997), Aberrant host responses to luminal bacteria in the pathogenesis of chronic intestinal inflammation, in "The immunobiology of H. pylori - from pathogenesis to prevention" (Ernst P.B., Michetti, P., Smith, P.D.) (pp. 167-182). Raven Press, New York.
63. Schultz, M., Sellon, R.K., Tonkonogy, S.L., Balish, E. & Sartor, R.B. (1997), EL-2 deficient mice raised under germfree conditions develop delayed mild focal intestinal inflammation and progressive loss of B cells. Gastroenterology, 112, A1086.
64. Schultz, M., Veltkamp, C., Dieleman, L.A., Wyrick, P.B., Tonkonogy, S.L. & Sartor, R.B. (1998), Continuous feeding of Lactobacillus plantarum attenuates established colitis in interleukin-10 deficient mice. Gastroenterology, 114 (in press).
65. Schwab, J.H. (1993), Phlogistic properties of peptidoglycan-polysaccharide polymers from cell walls of pathogenic and normal-flora bacteria which colonize humans. Infect. Immun., 61, 4535-4539.
66. Sellon, R., Tonkonogy, S., Grable, H., Kwon, J., Schultz, M., Balish, E., Rennick, D. & Sartor, R.B. (1997), Development of spontaneous colitis in IL-10 knockout mice requires normal enteric bacterial flora. Gastroenterology, 112, A1088.
67. Sutherland, L., Singleton, J. & Sessions, J. (1991), Double blind, placebo controlled trial of metronidazole in Crohn's disease. Gut, 32, 1071-1075.
68. Tabaqchali, S., O'Donoghue, D.P. & Bettelheim, K.A. (1978), Escherichia coli antibodies in patients with inflammatory bowel disease. Gut, 19, 108-113.
69. Taurog, J.D., Richardson, J.A., Croft, J.T. et al. (1994), The germfree state prevents development of gut and joint inflammation disease in HLA-B27 transgenic rats. J. Exp. Med., 180, 2359-2364.
70. Turunen, U., Färkkilä, M. & Hakala, K. (1994), A double blind, placebo controlled, six month ciprofloxacin treatment improves prognosis in ulcerative colitis. Gastroenterology, 106, A786.
71. Ursing, B., Alm, T., Barany, F., Bergelin, I., Ganrot-Norlin, K., Hoevels, J., Huitfeldt, B., Jarnerot, G., Krause, U., Krook, A., Lindstrom, B., Nordle, O. & Rosen, A. (1982), A comparative study of metronidazole and sulfasalazine for active Crohn's disease: the cooperative Crohn's disease study in Sweden. Gastroenterology, 83, 550-562.
72. Von Ritter, C. et al. (1988), The chemotactic peptide N-formyl methionyl-leucyl-phenylalanine increases mucosal permeability in the distal ileum of the rat. Gastroenterology, 95, 651-656.